HUP0004589A1 - Javított eljárás nukleinsav bevitelére harántcsikolt izomba és kombinált alkalmazása - Google Patents
Javított eljárás nukleinsav bevitelére harántcsikolt izomba és kombinált alkalmazásaInfo
- Publication number
- HUP0004589A1 HUP0004589A1 HU0004589A HUP0004589A HUP0004589A1 HU P0004589 A1 HUP0004589 A1 HU P0004589A1 HU 0004589 A HU0004589 A HU 0004589A HU P0004589 A HUP0004589 A HU P0004589A HU P0004589 A1 HUP0004589 A1 HU P0004589A1
- Authority
- HU
- Hungary
- Prior art keywords
- nucleic acid
- improved method
- intake
- transferring nucleic
- combination
- Prior art date
Links
- 108020004707 nucleic acids Proteins 0.000 title abstract 5
- 150000007523 nucleic acids Chemical class 0.000 title abstract 5
- 102000039446 nucleic acids Human genes 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 3
- 210000003205 muscle Anatomy 0.000 title 1
- 238000001727 in vivo Methods 0.000 abstract 2
- 210000003699 striated muscle Anatomy 0.000 abstract 2
- 239000013066 combination product Substances 0.000 abstract 1
- 229940127555 combination product Drugs 0.000 abstract 1
- 230000005684 electric field Effects 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0412—Specially adapted for transcutaneous electroporation, e.g. including drug reservoirs
- A61N1/0416—Anode and cathode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
A találmány tárgya javított eljárás nukleinsavak bevitelére vagy abevitel hatásfokát javítani képes termékekhez kapcsolt nukleinsavak invivo harántcsíkolt izomba történő bevitelére, valamint egy nukleinsavés a találmány szerinti beviteli eljárás kombinációja génterápiábantörténő alkalmazásukra. A találmány tárgyát képezi továbbá egynukleinsav és egy 1 és 800 V/cm közötti térerősségű elektromos mezőmint kombinációs termék harántcsíkolt izomba való in vivo egyidejű,különálló vagy az időben megosztott beadásra. Ó
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9708233A FR2765242B1 (fr) | 1997-06-30 | 1997-06-30 | Amelioration du transfert d'acide nucleique dans le muscle strie et combinaison permettant la mise en oeuvre du procede |
US6748897P | 1997-12-01 | 1997-12-01 | |
PCT/FR1998/001400 WO1999001158A1 (fr) | 1997-06-30 | 1998-06-30 | Amelioration du transfert d'acide nucleique dans le muscle strie et combinaison permettant la mise en oeuvre du procede |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0004589A1 true HUP0004589A1 (hu) | 2001-04-28 |
HUP0004589A3 HUP0004589A3 (en) | 2003-08-28 |
Family
ID=26233648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0004589A HUP0004589A3 (en) | 1997-06-30 | 1998-06-30 | Improved method for transferring nucleic acid into the striped muscle and combination therefor |
Country Status (16)
Country | Link |
---|---|
US (1) | US6939862B2 (hu) |
EP (1) | EP0991426B2 (hu) |
JP (1) | JP2002507985A (hu) |
KR (1) | KR20010020571A (hu) |
CN (1) | CN1261807A (hu) |
AT (1) | ATE275423T1 (hu) |
AU (1) | AU8444798A (hu) |
BR (1) | BR9810369A (hu) |
CA (1) | CA2294793A1 (hu) |
CZ (1) | CZ299473B6 (hu) |
DE (1) | DE69826124T3 (hu) |
HU (1) | HUP0004589A3 (hu) |
IL (1) | IL133710A0 (hu) |
NO (1) | NO328102B1 (hu) |
PL (1) | PL337583A1 (hu) |
WO (1) | WO1999001158A1 (hu) |
Families Citing this family (131)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010020570A (ko) * | 1997-06-30 | 2001-03-15 | 자끄 사비나 | 다세포 진핵 생물 세포중으로 개선된 핵산 전달방법 및이를 위한 콤비네이션 |
US20090239940A1 (en) * | 1997-07-22 | 2009-09-24 | Del Monte Federica | Treating heart failure and ventricular arrhythmias |
US6800484B2 (en) | 1998-06-24 | 2004-10-05 | Genetronics, Inc. | High efficiency transfection based on low electric field strength, long pulse length |
US6678556B1 (en) * | 1998-07-13 | 2004-01-13 | Genetronics, Inc. | Electrical field therapy with reduced histopathological change in muscle |
US7922709B2 (en) | 1998-07-13 | 2011-04-12 | Genetronics, Inc. | Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation |
EP1829973A3 (en) * | 1999-06-25 | 2008-01-09 | Genetronics, Inc. | High efficienty transfection based on low electric field strength, low pulse length |
EP1276500B1 (en) | 2000-03-13 | 2011-06-08 | Cornell Research Foundation, Inc. | Blocking leukocyte emigration and inflammation by interfering with cd99/hec2 |
AU5345901A (en) | 2000-04-13 | 2001-10-30 | Univ Rockefeller | Enhancement of antibody-mediated immune responses |
AU6475901A (en) | 2000-05-22 | 2001-12-03 | Merck And Company Inc | System and method for assessing the performance of a pharmaceutical agent delivery system |
EP1353723A2 (en) | 2000-11-17 | 2003-10-22 | Gendel Limited | Ablation of cells using combined electric field and ultrasound therapy |
US6821274B2 (en) | 2001-03-07 | 2004-11-23 | Gendel Ltd. | Ultrasound therapy for selective cell ablation |
DE60144198D1 (de) | 2000-12-28 | 2011-04-21 | Wyeth Llc | Rekombinantes schutzprotein aus streptococcus pneumoniae |
ATE448793T1 (de) | 2001-03-02 | 2009-12-15 | Univ Rockefeller | Rekombinante hybrid-allergenkonstrukte mit verringerter allergenität unter beibehaltung der immunogenität des natürlichen allergens |
US20040023910A1 (en) * | 2001-09-28 | 2004-02-05 | Zhiming Zhang | Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
JP2005518904A (ja) | 2002-03-07 | 2005-06-30 | マーク アンド カンパニー インコーポレイテッド | 電気的刺激の側面を備えた臨床用注射器 |
CA2487284A1 (en) | 2002-05-23 | 2003-12-04 | Gendel Limited | Ablation device |
WO2003100008A2 (en) | 2002-05-24 | 2003-12-04 | Schering Corporation | Neutralizing human anti-igfr antibody |
US7785608B2 (en) | 2002-08-30 | 2010-08-31 | Wyeth Holdings Corporation | Immunogenic compositions for the prevention and treatment of meningococcal disease |
US7468273B2 (en) | 2003-05-01 | 2008-12-23 | Meial Limited | Canine GHRH gene, polypeptides and methods of use |
WO2005023292A1 (en) | 2003-09-03 | 2005-03-17 | The General Hospital Corporation | Methods of treating restenosis |
US7833187B2 (en) | 2004-04-16 | 2010-11-16 | Nuvue Therapeutics, Inc. | Systems and methods for improving image-guided tissue ablation |
FR2880808A1 (fr) * | 2005-01-20 | 2006-07-21 | Yves Scherman | Dispositif pour l'administration de principe actif aux cellules et tissus a l'aide d'electrodes de surface non invasives |
US8101169B2 (en) * | 2005-02-23 | 2012-01-24 | The Board Of Trustees Of The Leland Stanford Junior University | Ocular gene therapy using avalanche-mediated transfection |
US7923251B2 (en) * | 2005-02-23 | 2011-04-12 | The Board Of Trustees Of The Leland Stanford Junior University | Method and apparatus for avalanche-mediated transfer of agents into cells |
DE602006013117D1 (de) | 2005-04-25 | 2010-05-06 | Merial Ltd | Nipah-virus-impfstoffe |
US8088382B2 (en) | 2005-07-05 | 2012-01-03 | Cornell Research Foundation, Inc. | Methods of inhibiting transendothelial migration of neutrophils and monocytes with anti-CD99L2 antibodies |
FR2889066B1 (fr) * | 2005-07-28 | 2007-11-09 | Centre Nat Rech Scient | Procede d'immunisation genetique par electrotransfert contre une toxine et antiserum susceptible d'etre obtenu par ledit procede |
US20080241184A1 (en) | 2005-08-25 | 2008-10-02 | Jules Maarten Minke | Canine influenza vaccines |
US7771995B2 (en) | 2005-11-14 | 2010-08-10 | Merial Limited | Plasmid encoding human BMP-7 |
EP1951751B1 (en) | 2005-11-14 | 2017-11-01 | Merial, Inc. | Gene therapy for renal failure |
ES2388567T3 (es) | 2006-10-19 | 2012-10-16 | Csl Limited | Anticuerpos anti-il-13r alfa 1 y usos de los mismos |
WO2008060813A2 (en) | 2006-10-19 | 2008-05-22 | Merck & Co., Inc. | High affinity antibody antagonists of interleukin-13 receptor alpha 1 |
AR064642A1 (es) | 2006-12-22 | 2009-04-15 | Wyeth Corp | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi |
UA100692C2 (ru) | 2007-05-02 | 2013-01-25 | Мериал Лимитед | Днк-плазмиды, имеющие повышенную экспрессию и стабильность |
AU2009231598B2 (en) | 2008-04-04 | 2015-03-12 | The Trustees Of The University Of Pennsylvania | Vaccines and immunotherapeutics using IL-28 and compositions and methods of using the same |
US8093043B2 (en) | 2008-06-04 | 2012-01-10 | New York University | β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis |
EP2147697A1 (en) | 2008-07-21 | 2010-01-27 | Centre National De La Recherche Scientifique-CNRS | Process and device for applying electric fields into conductive material |
EP2156860A1 (en) | 2008-08-20 | 2010-02-24 | Centre National De La Recherche Scientifique-CNRS | Method for producing insulated electrodes for applying electric fields into conductive material |
NO2356135T3 (hu) | 2008-11-05 | 2018-03-24 | ||
MX2011005604A (es) | 2008-11-28 | 2011-09-01 | Merial Ltd | Vacuna recombinante para influenza aviar y sus usos. |
WO2011032179A1 (en) | 2009-09-14 | 2011-03-17 | The Trustees Of The University Of Pennsylvania | Vaccines and immunotherapeutics comprising il-15 receptor alpha and/or nucleic acid molecules encoding the same, and methods for using the same |
KR101965337B1 (ko) | 2009-11-02 | 2019-04-03 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 구제역 바이러스(fmdv) 공통 단백질, 이를 위한 코딩 서열 및 이로부터 만들어진 백신 |
PE20121685A1 (es) | 2009-12-28 | 2012-12-28 | Merial Ltd | Antigeno ndv recombinante y usos del mismo |
US8298820B2 (en) | 2010-01-26 | 2012-10-30 | The Trustees Of The University Of Pennsylvania | Influenza nucleic acid molecules and vaccines made therefrom |
WO2011097640A1 (en) | 2010-02-08 | 2011-08-11 | The Trustees Of The University Of Pennsylvania | Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same |
US20130197612A1 (en) | 2010-02-26 | 2013-08-01 | Jack W. Lasersohn | Electromagnetic Radiation Therapy |
MA34087B1 (fr) | 2010-03-12 | 2013-03-05 | Merial Ltd | Vaccins recombinants contre le virus de la langue bleue et leurs utilisations |
WO2012025873A2 (en) | 2010-08-23 | 2012-03-01 | Wyeth Llc | STABLE FORMULATIONS OF NEISSERIA MENINGITIDIS rLP2086 ANTIGENS |
PE20140173A1 (es) | 2010-09-10 | 2014-02-20 | Wyeth Llc | Variantes no lipidadas de antigenos orf2086 de neisseria meningitidis |
JP6293485B2 (ja) | 2010-09-27 | 2018-03-14 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | コンセンサス抗原コンストラクトおよびそれらから作製されるワクチン、ならびにそれらを使用するマラリアの治療方法 |
SI3536703T1 (sl) | 2010-11-12 | 2022-04-29 | The Trustees Of The University Of Pennsylvania | Konsenzni prostatični antigeni, molekule nukleinske kisline, ki jih kodirajo in uporabe le-teh |
US11214610B2 (en) | 2010-12-01 | 2022-01-04 | H. Lundbeck A/S | High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris |
US9539324B2 (en) | 2010-12-01 | 2017-01-10 | Alderbio Holdings, Llc | Methods of preventing inflammation and treating pain using anti-NGF compositions |
US9067988B2 (en) | 2010-12-01 | 2015-06-30 | Alderbio Holdings Llc | Methods of preventing or treating pain using anti-NGF antibodies |
AU2011336470B8 (en) | 2010-12-01 | 2017-09-14 | Alderbio Holdings Llc | Anti-NGF compositions and use thereof |
US9884909B2 (en) | 2010-12-01 | 2018-02-06 | Alderbio Holdings Llc | Anti-NGF compositions and use thereof |
US9078878B2 (en) | 2010-12-01 | 2015-07-14 | Alderbio Holdings Llc | Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75 |
JP6099573B2 (ja) | 2011-01-31 | 2017-03-22 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 新規なヘルペス抗原をコードする核酸分子、それを含むワクチン及びその使用方法 |
WO2012109668A1 (en) | 2011-02-11 | 2012-08-16 | The Trustees Of The University Of Pennsylvania | Nucleic acid molecule encoding hepatitis b virus core protein and vaccine comprising the same |
US9238679B2 (en) | 2011-02-11 | 2016-01-19 | The Trustees Of The University Of Pennslyvania | Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same |
NZ618125A (en) | 2011-05-27 | 2016-03-31 | Merial Ltd | Genetic vaccines against hendra virus and nipah virus |
ES2674439T3 (es) | 2011-06-01 | 2018-06-29 | Merial, Inc. | Administración sin aguja de vacunas contra el VSRRP |
US9446114B2 (en) | 2011-07-11 | 2016-09-20 | Inovio Pharmaceuticals, Inc. | Cross-protective arenavirus vaccines and their method of use |
JP6407028B2 (ja) | 2011-12-12 | 2018-10-17 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | MRSAのPBP2a及びその断片を含むタンパク質、それをコードする核酸、並びにMRSA感染を予防する及び治療するための組成物及びそれらの使用 |
KR20220132652A (ko) | 2011-12-12 | 2022-09-30 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 개선된 il-12 유전적 컨스트럭트 및 백신을 포함하는 조성물, 면역치료제 및 이를 이용하는 방법 |
MX353786B (es) | 2012-02-14 | 2018-01-29 | Merial Inc | Vacunas de subunidades de rotavirus, metodos de preparacion y uso de las mismas. |
WO2013123242A1 (en) | 2012-02-14 | 2013-08-22 | Merial Limited | Recombinant poxviral vectors expressing both rabies and ox40 proteins, and vaccines made therefrom |
SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
SG10201602558UA (en) | 2012-03-09 | 2016-05-30 | Pfizer | Neisseria meningitidis compositions and methods thereof |
EP3326646A1 (en) | 2012-03-22 | 2018-05-30 | Merial, Inc. | Modified marek's disease virus, and vaccines made therefrom |
KR20140146651A (ko) | 2012-04-10 | 2014-12-26 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 인간 호흡기 합포체 바이러스 공통 항원, 핵산 컨스트럭트 및 이들로부터 제조된 백신, 및 이들을 사용하는 방법 |
EP4190350A1 (en) | 2012-04-12 | 2023-06-07 | The Trustees Of The University Of Pennsylvania | Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same |
ES2664069T3 (es) | 2012-06-13 | 2018-04-18 | Merial, Inc. | Vacunas contra BTV y AHSV de genoma reordenado |
AU2013358947B2 (en) | 2012-12-13 | 2016-10-20 | Inovio Pharmaceuticals, Inc. | WT1 vaccine |
WO2014107739A1 (en) | 2013-01-07 | 2014-07-10 | Eleven Biotherapeutics, Inc. | Antibodies against pcsk9 |
EP2964665B1 (en) | 2013-03-08 | 2018-08-01 | Pfizer Inc | Immunogenic fusion polypeptides |
KR20150130284A (ko) | 2013-03-15 | 2015-11-23 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 암 백신 및 이를 이용한 치료 방법 |
KR102276405B1 (ko) | 2013-03-15 | 2021-07-12 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | 구제역 바이러스 (fmdv) 공통 단백질, 그에 대한 코딩 서열 및 그로부터 제조된 백신 |
DK3028048T3 (en) | 2013-07-31 | 2019-01-21 | Bioventures Llc | COMPOSITIONS FOR TREATMENT AND PREVENTION OF CANCER TARGETING AGAINST TUMOR-ASSOCIATED CARBOHYDRATE ANTIGEN |
CA2923129C (en) | 2013-09-08 | 2020-06-09 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
CN105829341A (zh) | 2013-12-13 | 2016-08-03 | 宾夕法尼亚大学理事会 | Dna抗体构建体及其使用方法 |
CN107427566B (zh) | 2014-12-01 | 2021-08-17 | 宾夕法尼亚大学理事会 | Dna抗体构建体及其使用方法 |
BR112017017460A2 (pt) | 2015-02-19 | 2018-04-10 | Pfizer Inc. | composições de neisseria meningitidis e métodos das mesmas |
EP3337503A1 (en) | 2015-08-20 | 2018-06-27 | Merial, Inc. | Fcv recombinant vaccines and uses thereof |
EP4286002A3 (en) | 2015-09-29 | 2024-02-28 | Boehringer Ingelheim Animal Health USA Inc. | Canine parvovirus (cpv) virus-like particle (vlp) vaccines and uses thereof |
RU2714428C2 (ru) | 2015-11-23 | 2020-02-14 | Мериал, Инк. | Слитые белки fmdv-e2 и их применение |
TWI760322B (zh) | 2016-01-29 | 2022-04-11 | 美商百靈佳殷格翰動物保健美國有限公司 | 重組腺病毒載體裝載之fmdv疫苗及其用途 |
BR112018015893A2 (pt) | 2016-02-05 | 2019-03-06 | Inovio Pharmaceuticals Inc | vacinas de câncer e métodos de tratamento usando as mesmas |
JP7250520B2 (ja) | 2016-04-13 | 2023-04-03 | ヤンセン ファーマシューティカルズ,インコーポレーテッド | 組換えアルテリウイルスレプリコン系およびその使用 |
CN110073002A (zh) | 2016-10-17 | 2019-07-30 | 合成基因组公司 | 重组病毒复制子体系及其用途 |
WO2018106615A2 (en) | 2016-12-05 | 2018-06-14 | Synthetic Genomics, Inc. | Compositions and methods for enhancing gene expression |
AU2018215585B2 (en) | 2017-01-31 | 2022-03-17 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
JP7441169B2 (ja) | 2017-12-13 | 2024-02-29 | イノビオ ファーマシューティカルズ,インコーポレイティド | Muc16を標的とするがんワクチンおよびその使用 |
BR112020011443A2 (pt) | 2017-12-13 | 2020-12-01 | Inovio Pharmaceuticals, Inc. | molécula de ácido nucleico e seu uso, vetor e seu uso, composição, proteína e vacina |
JP7352547B2 (ja) | 2017-12-13 | 2023-09-28 | イノビオ ファーマシューティカルズ,インコーポレイティド | メソセリンを標的とするがんワクチンおよびその使用 |
EA202091516A1 (ru) | 2017-12-19 | 2020-11-03 | Янссен Сайенсиз Айрлэнд Анлимитед Компани | Способы и композиции для индукции иммунного ответа против вируса гепатита b (hbv) |
US11389531B2 (en) | 2017-12-19 | 2022-07-19 | Janssen Sciences Ireland Unlimited Company | Methods and apparatus for the delivery of hepatitis B virus (HBV) vaccines |
KR20200101416A (ko) | 2017-12-19 | 2020-08-27 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | B형 간염 바이러스(hbv) 백신 및 그 용도 |
MA51312A (fr) | 2017-12-19 | 2020-10-28 | Bavarian Nordic As | Méthodes et compositions permettant d'induire une réponse immunitaire contre le virus de l'hépatite b (vhb) |
EA202091513A1 (ru) | 2017-12-19 | 2020-09-09 | Янссен Сайенсиз Айрлэнд Анлимитед Компани | Вакцины против вируса гепатита b (hbv) и их применение |
US11083786B2 (en) | 2018-01-19 | 2021-08-10 | Janssen Pharmaceuticals, Inc. | Induce and enhance immune responses using recombinant replicon systems |
JP2022536945A (ja) | 2019-06-18 | 2022-08-22 | ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー | B型肝炎ウイルス(HBV)ワクチンおよびHBVを標的化するRNAiの組合せ |
WO2020255010A1 (en) | 2019-06-18 | 2020-12-24 | Janssen Sciences Ireland Unlimited Company | Combination of recombinant interleukin 12 construct and hepatitis b virus (hbv) vaccines |
US20220305115A1 (en) | 2019-06-18 | 2022-09-29 | Janssen Sciences Ireland Unlimited Company | Combination of hepatitis b virus (hbv) vaccines and pyridopyrimidine derivatives |
WO2020255009A2 (en) | 2019-06-18 | 2020-12-24 | Janssen Sciences Ireland Unlimited Company | Combination of hepatitis b virus (hbv) vaccines and anti-pd-1 antibody |
US20220305116A1 (en) | 2019-06-18 | 2022-09-29 | Janssen Sciences lreland Unlimited Company | Combination of hepatitis b virus (hbv) vaccines and capsid assembly modulators being sulfonamide derivatives |
WO2020255042A1 (en) | 2019-06-18 | 2020-12-24 | Janssen Sciences Ireland Unlimited Company | Combination of hepatitis b virus (hbv) vaccines and a pyrimidine derivative |
US20220305114A1 (en) | 2019-06-18 | 2022-09-29 | Janssen Sciences Ireland Unlimited Company | Combination of hepatitis b virus (hbv) vaccines and small molecule pdl1 or pd1 inhibitor |
CA3141238A1 (en) | 2019-06-18 | 2020-12-24 | Janssen Sciences Ireland Unlimited Company | Hepatitis b virus (hbv) vaccines and uses thereof |
WO2020255016A1 (en) | 2019-06-18 | 2020-12-24 | Janssen Sciences Ireland Unlimited Company | Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators |
WO2020255020A1 (en) | 2019-06-18 | 2020-12-24 | Janssen Sciences Ireland Unlimited Company | Combination of hepatitis b virus (hbv) vaccines and pd-l1 inhibitors |
CA3141323A1 (en) | 2019-06-18 | 2020-12-24 | Helen Horton | Recombinant interleukin 12 construct and uses thereof |
CN114630675A (zh) | 2019-06-18 | 2022-06-14 | 爱尔兰詹森科学公司 | 乙型肝炎病毒(hbv)疫苗和抗pd-1或抗pd-l1抗体的组合 |
EP3986456A1 (en) | 2019-06-18 | 2022-04-27 | Janssen Sciences Ireland Unlimited Company | Combination of hepatitis b virus (hbv) vaccines and hbv-targeting rnai |
WO2020255035A1 (en) | 2019-06-18 | 2020-12-24 | Janssen Sciences Ireland Unlimited Company | Combination of hepatitis b virus (hbv) vaccines and pyrimidine derivatives |
US20220233526A1 (en) | 2019-06-18 | 2022-07-28 | Janssen Sciences Ireland Unlimited Company | Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators |
WO2020254876A1 (en) | 2019-06-18 | 2020-12-24 | Janssen Sciences Ireland Unlimited Company | Virus-like particle delivery of hepatitis b virus (hbv) vaccines |
WO2020255013A1 (en) | 2019-06-18 | 2020-12-24 | Janssen Sciences Ireland Unlimited Company | Combination of hepatitis b virus (hbv) vaccines and capsid assembly modulators being amide derivatives |
WO2020255022A1 (en) | 2019-06-18 | 2020-12-24 | Janssen Sciences Ireland Unlimited Company | Combination of hepatitis b virus (hbv) vaccines and aminopyridine derivatives as hpk1 inhibitors |
CA3140707A1 (en) | 2019-06-18 | 2020-12-24 | Helen Horton | Combination of hepatitis b virus (hbv) vaccines and quinazoline derivatives |
WO2020255015A1 (en) | 2019-06-18 | 2020-12-24 | Janssen Sciences Ireland Unlimited Company | Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators |
WO2020255019A1 (en) | 2019-06-18 | 2020-12-24 | Janssen Sciences Ireland Unlimited Company | Combination of hepatitis b virus (hbv) vaccines and a quinazoline derivative |
WO2020255063A1 (en) | 2019-06-20 | 2020-12-24 | Janssen Sciences Ireland Unlimited Company | Carbohydrate nanocarrier delivery of hepatitis b virus (hbv) vaccines |
EP3986563A1 (en) | 2019-06-20 | 2022-04-27 | Janssen Sciences Ireland Unlimited Company | Lipid nanoparticle or liposome delivery of hepatitis b virus (hbv) vaccines |
EP4165183A1 (en) | 2020-06-12 | 2023-04-19 | University of Rochester | Encoding and expression of ace-trnas |
AU2021303478A1 (en) | 2020-07-08 | 2023-02-16 | Janssen Sciences Ireland Unlimited Company | RNA replicon vaccines against HBV |
TW202245809A (zh) | 2020-12-18 | 2022-12-01 | 美商詹森藥物公司 | 用於治療b型肝炎病毒感染之組合療法 |
EP4267740A1 (en) | 2020-12-28 | 2023-11-01 | Arcturus Therapeutics, Inc. | Transcription activator-like effector nucleases (talens) targeting hbv |
WO2023150753A1 (en) | 2022-02-07 | 2023-08-10 | University Of Rochester | Optimized sequences for enhanced trna expression or/and nonsense mutation suppression |
WO2023233290A1 (en) | 2022-05-31 | 2023-12-07 | Janssen Sciences Ireland Unlimited Company | Rnai agents targeting pd-l1 |
Family Cites Families (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4301794A (en) | 1978-10-18 | 1981-11-24 | Robert Tapper | Method for iontophoretic treatment |
US4411657A (en) | 1980-05-19 | 1983-10-25 | Anibal Galindo | Hypodermic needle |
JPS5810066A (ja) | 1981-07-10 | 1983-01-20 | 株式会社アドバンス | イオントフオレ−ゼ用プラスタ−構造体 |
US4476004A (en) | 1983-04-08 | 1984-10-09 | D.E.P. Systems, Inc. | Apparatus for electrofusion of biological particles |
US4441972A (en) | 1983-04-08 | 1984-04-10 | D.E.P. Systems, Inc. | Apparatus for electrofusion of biological particles |
US4639244A (en) | 1983-05-03 | 1987-01-27 | Nabil I. Rizk | Implantable electrophoretic pump for ionic drugs and associated methods |
DE3317415A1 (de) | 1983-05-13 | 1984-11-15 | Kernforschungsanlage Jülich GmbH, 5170 Jülich | Kammer zur behandlung von zellen im elektrischen feld |
US4622031A (en) | 1983-08-18 | 1986-11-11 | Drug Delivery Systems Inc. | Indicator for electrophoretic transcutaneous drug delivery device |
US4557723A (en) | 1983-08-18 | 1985-12-10 | Drug Delivery Systems Inc. | Applicator for the non-invasive transcutaneous delivery of medicament |
EP0140308B2 (en) | 1983-10-20 | 2001-10-17 | The Research Foundation Of State University Of New York | Regulation of gene expression by employing translational inhibition utilizing mRNA interfering complementary RNA |
US4578168A (en) | 1984-07-27 | 1986-03-25 | Biotronics | Apparatus for fusing live cells with electric fields |
FR2573436B1 (fr) | 1984-11-20 | 1989-02-17 | Pasteur Institut | Adn recombinant comportant une sequence nucleotidique codant pour un polypeptide determine sous le controle d'un promoteur d'adenovirus, vecteurs contenant cet adn recombinant, cellules eucaryotes transformees par cet adn recombinant, produits d'excretion de ces cellules transformees et leurs applications, notamment a la constitution de vaccins |
US6696420B1 (en) | 1984-11-20 | 2004-02-24 | Institut Pasteur | Adenoviral vector with a deletion in the E1A coding region expressing a hetorologous protein |
US4663292A (en) | 1984-12-21 | 1987-05-05 | Wong Daniel T | High-voltage biological macromolecule transfer and cell fusion system |
US4702732A (en) | 1984-12-24 | 1987-10-27 | Trustees Of Boston University | Electrodes, electrode assemblies, methods, and systems for tissue stimulation and transdermal delivery of pharmacologically active ligands |
AT385894B (de) | 1985-10-04 | 1988-05-25 | Basem Dr Nashef | Schlauchfoermige sonde |
US5049488A (en) | 1985-11-08 | 1991-09-17 | Genentech, Inc. | Method and nucleic acid for the preparation of lecithin:cholesterol acyltransferase |
US4695547A (en) | 1986-04-02 | 1987-09-22 | Jeffrey L. Hilliard | Probe for electrofusion, electroporation, or like procedure |
US5744133A (en) | 1986-08-13 | 1998-04-28 | Transgene S.A. | Expression of a tumor-specific antigen by a recombinant vector virus and use thereof in preventitive or curative treatment of the corresponding tumor |
FR2602790B1 (fr) | 1986-08-13 | 1990-06-01 | Transgene Sa | Expression d'un antigene specifique de tumeur par un virus vecteur recombinant et utilisation de celui-ci pour le traitement preventif ou curatif de la tumeur correspondante |
US6007806A (en) | 1986-08-13 | 1999-12-28 | Transgene S.A. | Expression of a tumor-specific antigen by a recombinant vector virus and use thereof in preventive or curative treatment of the corresponding tumor |
US4786277A (en) | 1986-11-21 | 1988-11-22 | Trustees Of Boston University | Electrodes, electrode assemblies, methods, and systems for tissue stimulation |
US5371003A (en) | 1987-05-05 | 1994-12-06 | Sandoz Ltd. | Electrotransformation process |
US5128257A (en) | 1987-08-31 | 1992-07-07 | Baer Bradford W | Electroporation apparatus and process |
US4970154A (en) | 1987-10-09 | 1990-11-13 | Baylor College Of Medicine | Method for inserting foreign genes into cells using pulsed radiofrequency |
RO114469B1 (ro) | 1987-12-15 | 1999-04-30 | Gene Shears Pty Ltd | Compus oligoribonucleotidic, procedeu de preparare si metoda de inactivare |
US5547467A (en) | 1988-01-21 | 1996-08-20 | Massachusettes Institute Of Technology | Method for rapid temporal control of molecular transport across tissue |
US5749847A (en) | 1988-01-21 | 1998-05-12 | Massachusetts Institute Of Technology | Delivery of nucleotides into organisms by electroporation |
DE68925030T2 (de) | 1988-01-21 | 1996-07-25 | Massachusetts Inst Technology | Molekültransport durch gewebe mit der verwendung von elektroporation. |
US5389069A (en) | 1988-01-21 | 1995-02-14 | Massachusetts Institute Of Technology | Method and apparatus for in vivo electroporation of remote cells and tissue |
US5693622A (en) * | 1989-03-21 | 1997-12-02 | Vical Incorporated | Expression of exogenous polynucleotide sequences cardiac muscle of a mammal |
US5119832A (en) | 1989-07-11 | 1992-06-09 | Ravi Xavier | Epidural catheter with nerve stimulators |
US5124259A (en) | 1989-08-23 | 1992-06-23 | Mitsui Toatsu Chemicals, Inc. | Method for electroporation |
US6228844B1 (en) * | 1991-11-12 | 2001-05-08 | Vical Incorporated | Stimulating vascular growth by administration of DNA sequences encoding VEGF |
US5236413B1 (en) | 1990-05-07 | 1996-06-18 | Andrew J Feiring | Method and apparatus for inducing the permeation of medication into internal tissue |
US5081990A (en) | 1990-05-11 | 1992-01-21 | New York University | Catheter for spinal epidural injection of drugs and measurement of evoked potentials |
US5499971A (en) | 1990-06-15 | 1996-03-19 | Cortrak Medical, Inc. | Method for iontophoretically delivering drug adjacent to a heart |
CA2081896A1 (en) | 1990-06-15 | 1991-12-16 | James E. Shapland | Drug delivery apparatus and method |
FR2681786A1 (fr) | 1991-09-27 | 1993-04-02 | Centre Nat Rech Scient | Vecteurs recombinants d'origine virale, leur procede d'obtention et leur utilisation pour l'expression de polypeptides dans des cellules musculaires. |
FR2688514A1 (fr) | 1992-03-16 | 1993-09-17 | Centre Nat Rech Scient | Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant. |
US5501662A (en) | 1992-05-22 | 1996-03-26 | Genetronics, Inc. | Implantable electroporation method and apparatus for drug and gene delivery |
US5814603A (en) | 1992-06-12 | 1998-09-29 | Affymax Technologies N.V. | Compounds with PTH activity |
US5607691A (en) | 1992-06-12 | 1997-03-04 | Affymax Technologies N.V. | Compositions and methods for enhanced drug delivery |
JPH063783A (ja) | 1992-06-19 | 1994-01-14 | Fuji Photo Film Co Ltd | ハロゲン化銀カラー写真感光材料 |
US5304120A (en) | 1992-07-01 | 1994-04-19 | Btx Inc. | Electroporation method and apparatus for insertion of drugs and genes into endothelial cells |
JP3099049B2 (ja) * | 1992-07-29 | 2000-10-16 | 農林水産省果樹試験場長 | 電気的細胞融合及び電気的核酸導入のための大量処理用電極 |
US5273525A (en) * | 1992-08-13 | 1993-12-28 | Btx Inc. | Injection and electroporation apparatus for drug and gene delivery |
US5688233A (en) | 1992-08-17 | 1997-11-18 | Genetronics, Inc. | Electronincorporation enhanced transdermal delivery of molecules |
US5464386A (en) | 1992-08-17 | 1995-11-07 | Genetronics, Inc. | Transdermal drug delivery by electroincorporation of vesicles |
US5318514A (en) | 1992-08-17 | 1994-06-07 | Btx, Inc. | Applicator for the electroporation of drugs and genes into surface cells |
US5462520A (en) | 1992-08-17 | 1995-10-31 | Genetronics, Inc. | Transsurface drug delivery by electrofusion of microbubbles to the tissue surface |
JP3351572B2 (ja) | 1992-10-05 | 2002-11-25 | 井上 聰一 | イオンクロマトグラフィーによる分析体の分離・分析方法、イオンクロマトグラフィー用両荷電具備固定相及び多機能液体クロマトグラフィーによる分析体の分離・分析方法 |
US5468223A (en) | 1992-11-30 | 1995-11-21 | C.N.R.S. Paris | Electrochemotherapy |
FR2703253B1 (fr) | 1993-03-30 | 1995-06-23 | Centre Nat Rech Scient | Applicateur d'impulsions electriques pour traitement de tissus biologiques. |
US5993434A (en) * | 1993-04-01 | 1999-11-30 | Genetronics, Inc. | Method of treatment using electroporation mediated delivery of drugs and genes |
US5702359A (en) | 1995-06-06 | 1997-12-30 | Genetronics, Inc. | Needle electrodes for mediated delivery of drugs and genes |
US5439440A (en) | 1993-04-01 | 1995-08-08 | Genetronics, Inc. | Electroporation system with voltage control feedback for clinical applications |
GB9317380D0 (en) * | 1993-08-20 | 1993-10-06 | Therexsys Ltd | Transfection process |
US5804566A (en) | 1993-08-26 | 1998-09-08 | The Regents Of The University Of California | Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides |
US5679647A (en) | 1993-08-26 | 1997-10-21 | The Regents Of The University Of California | Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
US5849719A (en) | 1993-08-26 | 1998-12-15 | The Regents Of The University Of California | Method for treating allergic lung disease |
DE4341424A1 (de) | 1993-12-04 | 1995-06-08 | Bosch Gmbh Robert | Kraftstoffeinspritzpumpe |
IL108775A (en) | 1994-02-25 | 2003-09-17 | Univ Ramot | Method for efficient incorporation of molecules into cells |
AU2947795A (en) | 1994-06-24 | 1996-01-19 | Cygnus, Inc. | Pulsatile delivery systems of biologically active agents using electro voltage pulsing for controlling membrane permeability |
US5471884A (en) | 1994-07-05 | 1995-12-05 | Motorola, Inc. | Gain-adjusting circuitry for combining two sensors to form a media isolated differential pressure sensor |
IT235163Y1 (it) | 1994-10-10 | 2000-03-31 | Ideal Standard Spa | Gruppo di tenuta per elementi maschio di stampi per la colatura di apparecchiature igienico-sanitarie |
US5641680A (en) * | 1994-11-14 | 1997-06-24 | Zhao; Xi | Gene transfer apparatus and method for using the same |
US5810762A (en) | 1995-04-10 | 1998-09-22 | Genetronics, Inc. | Electroporation system with voltage control feedback for clinical applications |
WO1997007826A1 (en) * | 1995-08-29 | 1997-03-06 | Cbr Laboratories, Inc. | In vivo electroporation of cells |
FR2738842B1 (fr) | 1995-09-15 | 1997-10-31 | Rhone Poulenc Rorer Sa | Molecule d'adn circulaire a origine de replication conditionnelle, leur procede de preparation et leur utilisation en therapie genique |
US5944710A (en) | 1996-06-24 | 1999-08-31 | Genetronics, Inc. | Electroporation-mediated intravascular delivery |
US5944726A (en) | 1996-08-23 | 1999-08-31 | Scimed Life Systems, Inc. | Stent delivery system having stent securement means |
US5960974A (en) | 1996-10-03 | 1999-10-05 | Advance Engineered Products Ltd. | Intermodal bulk container |
JPH10234366A (ja) | 1997-02-26 | 1998-09-08 | Hisamitsu Pharmaceut Co Inc | エレクトロポレーション用電極及びその製法、それを用いた製剤 |
KR100427786B1 (ko) * | 1997-04-03 | 2004-04-30 | 일렉트로우펙트 에이에스 | 약물과 핵산의 골격 근육 내 주입 장치 및 방법 |
US6241701B1 (en) * | 1997-08-01 | 2001-06-05 | Genetronics, Inc. | Apparatus for electroporation mediated delivery of drugs and genes |
US6055453A (en) | 1997-08-01 | 2000-04-25 | Genetronics, Inc. | Apparatus for addressing needle array electrodes for electroporation therapy |
WO1999036563A1 (en) | 1998-01-14 | 1999-07-22 | Emed Corporation | Electrically mediated cellular expression |
EP2428249B1 (en) * | 1998-07-13 | 2015-10-07 | Inovio Pharmaceuticals, Inc. | Skin and muscle-targeted gene therapy by pulsed electrical field |
US6678556B1 (en) | 1998-07-13 | 2004-01-13 | Genetronics, Inc. | Electrical field therapy with reduced histopathological change in muscle |
-
1998
- 1998-06-30 DE DE69826124T patent/DE69826124T3/de not_active Expired - Lifetime
- 1998-06-30 EP EP98935067A patent/EP0991426B2/fr not_active Expired - Lifetime
- 1998-06-30 CZ CZ0475599A patent/CZ299473B6/cs not_active IP Right Cessation
- 1998-06-30 KR KR1019997012481A patent/KR20010020571A/ko not_active Application Discontinuation
- 1998-06-30 JP JP50653099A patent/JP2002507985A/ja active Pending
- 1998-06-30 WO PCT/FR1998/001400 patent/WO1999001158A1/fr active IP Right Grant
- 1998-06-30 CN CN98806671A patent/CN1261807A/zh active Pending
- 1998-06-30 AU AU84447/98A patent/AU8444798A/en not_active Abandoned
- 1998-06-30 IL IL13371098A patent/IL133710A0/xx unknown
- 1998-06-30 AT AT98935067T patent/ATE275423T1/de not_active IP Right Cessation
- 1998-06-30 PL PL98337583A patent/PL337583A1/xx not_active Application Discontinuation
- 1998-06-30 HU HU0004589A patent/HUP0004589A3/hu unknown
- 1998-06-30 BR BR9810369-5A patent/BR9810369A/pt not_active IP Right Cessation
- 1998-06-30 CA CA002294793A patent/CA2294793A1/fr not_active Abandoned
-
1999
- 1999-12-29 NO NO19996542A patent/NO328102B1/no not_active IP Right Cessation
-
2001
- 2001-11-07 US US09/986,033 patent/US6939862B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2002507985A (ja) | 2002-03-12 |
EP0991426A1 (fr) | 2000-04-12 |
US20030073653A1 (en) | 2003-04-17 |
NO996542L (no) | 2000-02-17 |
CA2294793A1 (fr) | 1999-01-14 |
EP0991426B1 (fr) | 2004-09-08 |
AU8444798A (en) | 1999-01-25 |
EP0991426B2 (fr) | 2007-03-28 |
ATE275423T1 (de) | 2004-09-15 |
DE69826124T3 (de) | 2007-10-11 |
CN1261807A (zh) | 2000-08-02 |
PL337583A1 (en) | 2000-08-28 |
IL133710A0 (en) | 2001-04-30 |
DE69826124T2 (de) | 2005-09-15 |
CZ475599A3 (cs) | 2000-07-12 |
NO328102B1 (no) | 2009-12-07 |
NO996542D0 (no) | 1999-12-29 |
KR20010020571A (ko) | 2001-03-15 |
US6939862B2 (en) | 2005-09-06 |
DE69826124D1 (de) | 2004-10-14 |
WO1999001158A1 (fr) | 1999-01-14 |
BR9810369A (pt) | 2000-09-05 |
CZ299473B6 (cs) | 2008-08-06 |
HUP0004589A3 (en) | 2003-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0004589A1 (hu) | Javított eljárás nukleinsav bevitelére harántcsikolt izomba és kombinált alkalmazása | |
HUP0004728A1 (hu) | Javított eljárás nukleinsav bevitelére többsejtes eukarióta szervezet sejtjeibe és kombinált alkalmazása | |
DE69636032D1 (de) | Plasmid zur verabreichung von nukleine säuren und verwendungsverfahren | |
WO1996021470A3 (en) | Compositions of nucleic acid and viscosity-increasing polymers for use in gene therapy | |
CA2257133A1 (en) | Human dnase i hyperactive variants | |
WO1998055495A3 (en) | Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof | |
FI962799A (fi) | Nukleiinihappoja sisältävä valmiste, sen valmistus ja käyttö | |
FI970115A0 (fi) | Nukeliinihappoja sisältävä valmiste, sen valmistus ja käytöt | |
DE69837274D1 (de) | Verfahren zur verkapselung von nukleinsäuren in lipiddoppelschichten | |
IL115199A (en) | Composition comprising a polynucleic acid molecule in a liposome and method using said composition | |
HUP9800049A3 (en) | Amino acid compositions and use thereof in clinical nutrition, and use of the said amino acids for preparing pharmaceutical compns. for the diminution of tnf | |
CA2295199A1 (en) | Method for treating vascular proliferative diseases with p27 and fusions thereof | |
NZ331063A (en) | Isolated nucleotide sequences encoding for mature LS- DNase which is resistant to actin inhibition | |
WO1999024077A3 (en) | Compositions and methods for targeted delivery of biologically-active factors | |
AUPN154295A0 (en) | Nucleic acid molecule encoding a protein with avian gamma-interferon activity | |
HUP0004577A1 (hu) | Kationos nukleinsav transzfekciós ágensek új csoportja | |
AU3762699A (en) | (nr-cam) gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors | |
AU3333399A (en) | Nucleotide sequence expressing human fatty acid transport protein and corresponding aminoacid sequence. use for the regulation of fatty acids metabolism | |
CA2250433A1 (en) | Human dnase ii | |
BG101846A (en) | HUMAN DNase I VARIANTS | |
HU0003279D0 (en) | Process for preparation of metabolic products and nucleotide sequences encoding for the sod gene | |
WO2002016586A3 (en) | Adenosine deaminase homolog | |
WO2000068385A3 (en) | Novel nucleic acids and proteins with growth hormone activity | |
AU6358096A (en) | New immunoregulatory protein lst-1 | |
CA2242562A1 (en) | Human dnase resistant to actin inhibition |